Biomimetic bioartificial livers are liver organoids based on synthetic equivalents of the human extracellular matrix (ECM) which will be seeded with human cells.
Cleveland BioLabs said Monday that it has received a $4 million contract from a Russian government ministry to support the Buffalo-based drugmaker's development of a new drug to help ensure success of bone marrow transplants in patients.
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the quarter ended June 30, 2012.
BUFFALO, N.Y. — Cleveland BioLabs, Inc. today announced that, through a wholly-owned Russian subsidiary, it has signed a contract valued at 139 million rubles, or approximately $4 million (based on current …
By Scott Matusow, Contributor Trying to find companies that represent the future of the biotech sector can be tricky for investors. The sector currently leads the market because Food and Drug Administration …
Ideal Cures, a leading player based here in film coating material for tablets, pellets and granules of pharma, health and dietary supplement companies, has developed an extended delivery system for tablets used for all classes of drug.
OSLO, NORWAY– – Bionor Pharma ASA announced today that the HIV expert from the UK based St. George's University of London, Professor Angus "Gus" Dalgleish is joining Bionor's Clinical Advisory …
Research and Markets has announced the addition of GlobalData's new report "End-stage Renal Disease Therapeuti
GIA announces the release of a comprehensive global report on Acute Myeloid Leukemia (AML) Therapeutics markets. The global market for Acute Myeloid Leukemia (AML) Therapeutics is projected to reach US$243 million by the year 2017, primarily driven by …
In a recent Penny Stock Detectives article, editor Danny Esposito argues that in spite of the controversy surrounding stem cell research worldwide, biotech companies are encouraging research in the area because of its potential to revolutionize treatme…